Chimoto Tadash | Drug Safety & Disposition Research Laboratories, Eisai Co., Lid.

スポンサーリンク

概要

• 同名の論文著者
• Drug Safety & Disposition Research Laboratories, Eisai Co., Lid.の論文著者

関連著者

• Sagami Fumio

  第一三共安全性研究所

• Sagami Fumio

  Drug Safety Research Laboratories Eisai Co. Ltd.

• Sagami Fumio

  Subcommittee Of Non-clinical Evaluation Drug Evaluation Committee Japan Pharmaceutical Manufacturers

• Sagami Fumio

  Department Of Drug Safety Research Eisai Kawashima Research Laboratories Eisai Co. Ltd.

• AOKI Toyohiko

  Drug Safety Research Laboratories, Eisai Co., Ltd.

• Aoki Toyohiko

  Global Drug Safety Eisai Co. Ltd.

• TSUKIDATE Kazuo

  Drug Safety Research Laboratories, Eisai Co., Ltd

• SATO Gen

  Drug Safety Research Laboratories

• Sato Gen

  Drug Safety And Disposition

• Sato Gen

  Drug Safety Research Laboratories Eisai Co. Ltd.

• HOSOKAWA Satoru

  Drug Safety Research Lab., Eisai Co., Ltd.

• Tsukidate Kazuo

  Global Drug Safety Eisai Co. Ltd.

• Tsukidate Kazuo

  Drug Safety Research Lab. Eisai Co. Ltd.

• CHIMOTO Tadashi

  Drug Safety and Disposition

• SUMIGAMA Shuji

  Drug Safety & Disposition Research Laboratories, Eisai Co., Lid.

• Sumigama Shuji

  Drug Safety & Disposition Research Laboratories Eisai Co. Lid.

• Hosokawa Satoru

  Drug Safety And Disposition

• Aoki Toyohiko

  Drug Safety Japan Global Drug Safety Biopharmaceutical Assessments Core Function Unit

• Sagami Fumio

  Drug Safety Research Laboratories Eisai Co. Ltb.

• Chimoto Tadash

  Drug Safety & Disposition Research Laboratories, Eisai Co., Lid.

もっと見る 閉じる

著作論文

• TOXICOLOGICAL RESPONSE OF RATS TO A NOVEL MONOAMINE OXIDASE TYPE-A INHIBITOR, (5R)-3-[2-((1S)-3-CYANO-1-HYDROX-YPROPYL)BENZOTHIAZOL-6-YL]-5-METHOXYMETHYL-2-OXAZOLIDI-NONE (E2011), ORALLY ADMINISTERED FOR 13 WEEKS

スポンサーリンク